Management of Metastatic Gastric Cancer | MDedge Hematology and Oncology
ESMO 2020: Phase 3 CheckMate 649 Trial
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS - Annals of Oncology
Neoadjuvant and Adjuvant Therapy for Gastric Cancer | MDedge Hematology and Oncology
Immunotherapy for gastric cancer: a 2021 update | Immunotherapy
Gastrointestinal Cancer Clinical Trials | Study Connect
Gastric cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up - European Journal of Surgical Oncology
Modern Immunotherapy for the Treatment of Advanced Gastrointestinal Cancers
Clinical Trial Results With Advanced HER2-positive Gastric Cancer | Patients
Second-Line Treatment of Advanced Gastric Cancer: Where Do We Stand? in: Journal of the National Comprehensive Cancer Network Volume 13 Issue 10 (2015)
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study - The Lancet ...
Clinical Trials - GI Cancer
Clinical Implementation of Precision Medicine in Gastric Cancer
Plethora of Clinical Trials Explore Gastric Cancer Treatments
Landmark clinical trials of HER2-positive gastric cancer | Download Scientific Diagram
Unmet needs and challenges in gastric cancer: The way forward - Cancer Treatment Reviews
No Stomach For Cancer - Post-Gastrectomy Clinical Trial Continuous Glucose Monitoring to Reduce Hypoglycemia and Improve Safety in Patients With Hypoglycemia After Gastric Surgery https://clinicaltrials.gov/ct2/show/NCT03353415 | Facebook
Current Clinical Trials Assessing the Role of Immunotherapy in Gastric... | Download Table
Practice changing clinical trials in operable gastric cancer | Download Table
Gastric cancer: Translating novels concepts into clinical practice - Cancer Treatment Reviews
Hereditary diffuse gastric cancer: updated clinical practice guidelines - The Lancet Oncology
Novomics
Ongoing phase III trials of targeted therapies in advanced gastric cancer. | Download Table
Importance of Clinical Trials for Gastric Cancer
Recently completed phase II/III clinical trials of third-line therapy... | Download Scientific Diagram
Plethora of Clinical Trials Explore Gastric Cancer Treatments
